These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 10815892

  • 21. Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours.
    Cheeseman SL, Brannan M, McGown A, Khan P, Gardner C, Gumbrell L, Dickens D, Ranson M.
    Br J Cancer; 2000 Dec; 83(12):1599-606. PubMed ID: 11104552
    [Abstract] [Full Text] [Related]

  • 22. Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors.
    de Jonge MJ, van der Gaast A, Planting AS, van Doorn L, Lems A, Boot I, Wanders J, Satomi M, Verweij J.
    Clin Cancer Res; 2005 May 15; 11(10):3806-13. PubMed ID: 15897580
    [Abstract] [Full Text] [Related]

  • 23. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.
    Stevenson JP, Rosen M, Sun W, Gallagher M, Haller DG, Vaughn D, Giantonio B, Zimmer R, Petros WP, Stratford M, Chaplin D, Young SL, Schnall M, O'Dwyer PJ.
    J Clin Oncol; 2003 Dec 01; 21(23):4428-38. PubMed ID: 14645433
    [Abstract] [Full Text] [Related]

  • 24. A phase I and pharmacokinetic study of 1843U89, a noncompetitive inhibitor of thymidylate synthase, in patients with advanced solid malignancies.
    Schwartz G, Johnson TR, Goetz A, Burris H, Smetzer L, Lampkin T, Sailstad J, Hohneker JA, Von Hoff DD, Rowinsky EK.
    Clin Cancer Res; 2001 Jul 01; 7(7):1901-11. PubMed ID: 11448903
    [Abstract] [Full Text] [Related]

  • 25. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K, Kobayashi M, Kojima H, Hirabayashi N, Kataoka M, Araki K, Matsui T, Takiyama W, Miyashita Y, Nakazato H, Nakao A, Sakamoto J.
    Jpn J Clin Oncol; 2005 Jun 01; 35(6):332-7. PubMed ID: 15961435
    [Abstract] [Full Text] [Related]

  • 26. Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumors.
    Dittrich C, Dumez H, Calvert H, Hanauske A, Faber M, Wanders J, Yule M, Ravic M, Fumoleau P.
    Clin Cancer Res; 2003 Nov 01; 9(14):5195-204. PubMed ID: 14613999
    [Abstract] [Full Text] [Related]

  • 27. Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer.
    Takano M, Kikuchi Y, Kita T, Suzuki M, Ohwada M, Yamamoto T, Yamamoto K, Inoue H, Shimizu K.
    Anticancer Res; 2002 Nov 01; 22(3):1833-8. PubMed ID: 12168878
    [Abstract] [Full Text] [Related]

  • 28. Phase I study of combined pegylated liposomal doxorubicin with protracted daily topotecan for ovarian cancer.
    Mirchandani D, Hochster H, Hamilton A, Liebes L, Yee H, Curtin JP, Lee S, Sorich J, Dellenbaugh C, Muggia FM.
    Clin Cancer Res; 2005 Aug 15; 11(16):5912-9. PubMed ID: 16115933
    [Abstract] [Full Text] [Related]

  • 29. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J, Modiano M, Clairmont C, Lambert P, Savaraj N, Doyle T, Sznol M.
    Clin Cancer Res; 2003 Sep 15; 9(11):4092-100. PubMed ID: 14519631
    [Abstract] [Full Text] [Related]

  • 30. Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group Study.
    Whitlock JA, Krailo M, Reid JM, Ruben SL, Ames MM, Owen W, Reaman G, Children's Oncology Group Study.
    J Clin Oncol; 2005 Dec 20; 23(36):9179-86. PubMed ID: 16361620
    [Abstract] [Full Text] [Related]

  • 31. Satraplatin, an oral platinum, administered on a five-day every-five-week schedule: a pharmacokinetic and food effect study.
    Ricart AD, Sarantopoulos J, Calvo E, Chu QS, Greene D, Nathan FE, Petrone ME, Tolcher AW, Papadopoulos KP.
    Clin Cancer Res; 2009 Jun 01; 15(11):3866-71. PubMed ID: 19458055
    [Abstract] [Full Text] [Related]

  • 32. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K.
    Jpn J Clin Oncol; 2006 Apr 01; 36(4):218-23. PubMed ID: 16684860
    [Abstract] [Full Text] [Related]

  • 33. Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors.
    Rubin EH, Rothermel J, Tesfaye F, Chen T, Hubert M, Ho YY, Hsu CH, Oza AM.
    J Clin Oncol; 2005 Dec 20; 23(36):9120-9. PubMed ID: 16301595
    [Abstract] [Full Text] [Related]

  • 34. A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia.
    Gimsing P, Hansen M, Knudsen LM, Knoblauch P, Christensen IJ, Ooi CE, Buhl-Jensen P.
    Eur J Haematol; 2008 Sep 20; 81(3):170-6. PubMed ID: 18510700
    [Abstract] [Full Text] [Related]

  • 35. Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks.
    Minami H, Fujii H, Igarashi T, Itoh K, Tamanoi K, Oguma T, Sasaki Y.
    Clin Cancer Res; 2001 Oct 20; 7(10):3056-64. PubMed ID: 11595695
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486A in phase I studies in patients with advanced cancers.
    Zhou H, Choi L, Lau H, Bruntsch U, Vries EE, Eckhardt G, Oosterom AT, Verweij J, Schran H, Barbet N, Linnartz R, Capdeville R.
    J Clin Pharmacol; 2000 Mar 20; 40(3):275-83. PubMed ID: 10709156
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [A phase I study of DWA2114R].
    Ariyoshi Y, Wakui A, Hasegawa K, Niitani H, Ogawa M, Sakai Y, Majima H, Furue H, Miyake H, Taguchi T.
    Gan To Kagaku Ryoho; 1992 May 20; 19(5):685-93. PubMed ID: 1580642
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.